The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C

International Journal of Biochemistry and Cell Biology

Volumn 38, Issue 3, 2006, Pages 430-443

  Bachmann, Malte ^a,e   Kosan, Christian ^a   Xing, Pei Xiang ^b   Montenarh, Mathias ^c   Hoffmann, Ingrid ^d   Möröy, Tarik ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b AUSTIN RESEARCH INSTITUTE   (Australia)

^c SAARLAND UNIVERSITY   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e Pharmazentrum Frankfurt   (Germany)

Author keywords

Cdc25C Phosphatase; Cell cycle; G2 M checkpoint; Pim 1 kinase

Indexed keywords

BLEOMYCIN; PROTEIN; PROTEIN C TAK1; PROTEIN KINASE PIM 1; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CYCLE G2 PHASE; CHEMICAL ANALYSIS; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIUM CELL; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION;

ANIMALS; CDC25 PHOSPHATASE; CELL CYCLE; CELL CYCLE PROTEINS; CERCOPITHECUS AETHIOPS; COS CELLS; HELA CELLS; HUMANS; K562 CELLS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-PIM-1; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 29244464759     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2005.10.010     Document Type: Article

References (55)

1. T.L. Aho, J. Sandholm, K.J. Peltola, H.P. Mankonen, M. Lilly, and P.J. Koskinen Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser1 12 gatekeeper site FEBS Lett. 571 1-3 2004 43 49
2. I. Alevizos, M. Mahadevappa, X. Zhang, H. Ohyama, Y. Kohno, and M. Posner Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis Oncogene 20 2001 6196 6201
3. J.D. Allen, E. Verhoeven, J. Domen, M. van der Valk, and A. Berns Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc Oncogene 15 1997 1133 1141
4. M. Bachmann, H. Hennemann, P.X. Xing, I. Hoffmann, and T. Möröy The oncogenic serine/threonine kinase Pim-1 phosphorylates and inhibits the activity of Cdc25C-associated kinase 1 (C-TAK1): A novel role for Pim-1 at the G2/M cell cycle checkpoint J. Biol. Chem. 279 2004 48319 48328
5. N. Bhattacharya, Z. Wang, C. Davitt, I.F. McKenzie, P.X. Xing, and N.S. Magnuson Pim-1 associates with protein complexes necessary for mitosis Chromosoma 111 2002 80 95
6. I. Blomberg, and I. Hoffmann Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases Mol. Cell. Biol. 19 1999 6183 6194
7. K.E. Borg, M. Zhang, D. Hegge, R.L. Stephen, D.J. Buckley, and N.S. Magnuson Prolactin regulation of pim-1 expression: Positive and negative promoter elements Endocrinology 140 1999 5659 5668
8. A.R. Buckley, D.J. Buckley, M.A. Leff, D.S. Hoover, and N.S. Magnuson Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells Endocrinology 136 1995 5252 5259
9. X.P. Chen, J.A. Losman, S. Cowan, E. Donahue, S. Fay, and B.Q. Vuong Pim serine/threonine kinases regulate the stability of Socs-1 protein Proc. Natl. Acad. Sci. U.S.A. 99 2002 2175 2180
10. H.T. Cuypers, G. Selten, W. Quint, M. Zijlstra, E.R. Maandag, and W. Boelens Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region Cell 37 1984 141 150
11. F. Dautry, D. Weil, J. Yu, and A. Dautry-Varsat Regulation of pim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines J. Biol. Chem. 263 33 1988 17615 17620
12. S.M. Dhanasekaran, T.R. Barrette, D. Ghosh, R. Shah, S. Varambally, and K. Kurachi Delineation of prognostic biomarkers in prostata cancer Nature 412 2001 822 826
13. J. Domen, van der Lugt NMT, A. Clarke, M. Hooper, and A. Berns Impaired interleukin-3 response in Pim-1-deficient bone marrow-derived mast cells Blood 82 1993 1445 1452
14. J. Domen, N.M. van der Lugt, P.W. Laird, C.J. Saris, and A. Berns Analysis of Pim-1 function in mutant mice Leukemia 7 Suppl 2 1993 108 112
15. A. Eichmann, L. Yuan, C. Breant, K. Alitalo, and P.J. Koskinen Developmental expression of pim kinases suggests functions also outside of the hematopoietic system Oncogene 19 2000 1215 1224
16. M. Friedmann, M.S. Nissen, D.S. Hoover, R. Reeves, and N.S. Magnuson Characterization of the proto-oncogene pim-1: Kinase activity and substrate recognition sequence Arch. Biochem. Biophys. 298 1992 594 601
17. P.R. Graves, C.M. Lovly, G.L. Uy, and H. Piwnica-Worms Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding Oncogene 20 2001 1839 1851
18. I. Hassepass, and I. Hoffmann Assaying Cdc25 phosphatase activity Methods Mol. Biol. 281 2004 153 162
19. Y. Ishibashi, H. Maita, M. Yano, N. Koike, K. Tamai, and H. Ariga Pim-1 translocates sorting nexin 6/TRAF4-associated factor 2 from cytoplasm to nucleus FEBS Lett. 506 2001 33 38
20. R. Jaster, E. Tschirch, T. Bittorf, and J. Brock Interferon-alpha inhibits proliferation of Ba/F3 cells by interfering with interleukin-3 action Cell Signal. 11 1999 769 775
21. R. Jaster, E. Tschirch, T. Bittorf, and J. Brock Role of STAT5 in interferon-alpha signal transduction in Ba/F3 cells Cell Signal. 11 1999 331 335
22. N. Koike, H. Maita, T. Taira, H. Ariga, and S.M. Iguchi-Ariga Identification of heterochromatin protein 1 (HP1) as a phosphorylation target by Pim-1 kinase and the effect of phosphorylation on the transcriptional repression function of HP1 FEBS Lett. 467 2000 17 21
23. J.S. Krumenacker, D.J. Buckley, M.A. Leff, J.T. McCormack, G. de Jong, and P.W. Gout Prolactin receptor signaling: Shared components with the T-cell antigen receptor in Nb2 lymphoma cells Endocrine 9 2 1998 163 170
24. P.W. Laird, N.M. van der Lugt, A. Clarke, J. Domen, K. Linders, and J. McWhir In vivo analysis of Pim-1 deficiency Nucleic Acids Res. 21 20 1993 4750 4755
25. J.D. Leverson, P.J. Koskinen, F.C. Orrico, E.M. Rainio, K.J. Jalkanen, and A.B. Dash Pim-1 kinase and p100 cooperate to enhance c-Myb activity Mol. Cell. 2 1998 417 425
26. M. Lilly, and A. Kraft Enforced expression of the Mr 33 000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells Cancer Res. 57 1997 5348 5355
27. M. Lilly, J. Sandholm, J.J. Cooper, P.J. Koskinen, and A. Kraft The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway Oncogene 18 1999 4022 4031
28. H. Maita, Y. Harada, D. Nagakubo, H. Kitaura, M. Ikeda, and K. Tamai PAP-1, a novel target protein of phosphorylation by pim-1 kinase Eur. J. Biochem. 267 2000 5168 5178
29. S.S. Margolis, S. Walsh, D.C. Weiser, M. Yoshida, S. Shenolikar, and S. Kornbluth PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation EMBO J. 22 2003 5734 5745
30. S. Matikainen, T. Sareneva, T. Ronni, A. Lehtonen, P.J. Koskinen, and I. Julkunen Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells Blood 93 1999 1980 1991
31. T. Mochizuki, C. Kitanaka, K. Noguchi, T. Muramatsu, A. Asai, and Y. Kuchino Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase Implications for the Pim-1-mediated activation of the c-Myc signalling pathway J. Biol. Chem. 274 1999 18659 18666
32. T. Möröy, A. Grzeschiczek, S. Petzold, and K.U. Hartmann Expression of a Pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice Proc. Natl. Acad. Sci. U.S.A. 90 1993 10734 10738
33. M.L. Mucenski, D.J. Gilbert, B.A. Taylor, N.A. Jenkins, and N.G. Copeland Common sites of viral integration in lymphomas arising in AKXD recombinant inbred mouse strains Oncogene Res. 2 1987 33 48
34. M. Narimatsu, H. Maeda, S. Itoh, T. Atsumi, T. Ohtani, and K. Nishida Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in T cells Mol. Cell. Biol. 21 2001 6615 6625
35. T. Nosaka, T. Kawashima, K. Misawa, K. Ikuta, A.L. Mui, and T. Kitamura STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells EMBO J. 18 1999 4754 4765
36. R. Padma, and L. Nagarajan The human PIM-1 gene product is a protein serine kinase Cancer Res. 51 1991 2486 2489
37. C.K. Palaty, I. Clark-Lewis, D. Leung, and S.L. Pelech Phosphorylation site substrate specificity determinants for the Pim-1 protooncogene-encoded protein kinase Biochem. Cell. Biol. 75 1997 153 162
38. C.K. Palaty, G. Kalmar, G. Tai, S. Oh, L. Amankawa, and M. Affolter Identification of the autophosphorylation sites of the Xenopus laevis Pim-1 proto-oncogene-encoded protein kinase J. Biol. Chem. 272 1997 10514 10521
39. K.J. Peltola, K. Paukku, T.L. Aho, M. Ruuska, O. Silvennoinen, and P.J. Koskinen Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3 Blood 103 2004 3744 3750
40. C.Y. Peng, P.R. Graves, S. Ogg, R.S. Thoma, M.J.3rd Byrnes, and Z. Wu C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding Cell Growth Differ. 9 1998 197 208
41. T.J. Pircher, S. Zhao, J.N. Geiger, B. Joneja, and D.M. Wojchowski Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death Oncogene 19 2000 3684 3692
42. Y.W. Qian, E. Erikson, F.E. Taieb, and J.L. Maller The polo-like kinase Plx1 is required for activation of the phosphatase Cdc25C and cyclin B-Cdc2 in Xenopus oocytes Mol. Biol. Cell. 12 2001 1791 1799
43. E.M. Rainio, J. Sandholm, and P.J. Koskinen Cutting edge: Transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase J. Immunol. 168 2002 1524 1527
44. A.K. Roshak, E.A. Capper, C. Imburgia, J. Fornwald, G. Scott, and L.A. Marshall The human polo-like kinase, PLK, regulates cdc2/cyclin B through phosphorylation and activation of the cdc25C phosphatase Cell Signal. 2000 405 411
45. C.J. Saris, J. Domen, and A. Berns The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG EMBO J. 10 1991 655 664
46. G. Selten, H.T. Cuypers, and A. Berns Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas EMBO J. 4 1985 1793 1798
47. T. Shirogane, T. Fukada, J.M. Muller, D.T. Shima, M. Hibi, and T. Hirano Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis Immunity 11 1999 709 719
48. C.G. Takizawa, and D.O. Morgan Control of mitosis by changes in the subcellular location of cyclin-B 1-Cdk1 and Cdc25C Curr. Opin. Cell. Biol. 12 2000 658 665
49. N.M. van der Lugt, J. Domen, E. Verhoeven, K. Linders, H. van der Gulden, and J. Allen Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2 EMBO J. 14 1995 2536 2544
50. M. van Lohuizen, S. Verbeek, P. Krimpenfort, J. Domen, C. Saris, and T. Radaszkiewicz Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors Cell 56 1989 673 682
51. Z. Wang, N. Bhattacharya, M.K. Meyer, H. Seimiya, T. Tsuruo, and J.A. Tonani Pim-1 negatively regulates the activity of PTP-U2S phosphatase and influences terminal differentiation and apoptosis of monoblastoid leukemia cells Arch. Biochem. Biophys. 39 2001 9 18
52. Z. Wang, N. Bhattacharya, P.F. Mixter, W. Wei, J. Sedivy, and N.S. Magnuson Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase Biochim. Biophys. Acta 1593 2002 45 55
53. L.M. Winn, W. Lei, and S.A. Ness Pim-1 phosphorylates the DNA binding domain of c-Myb Cell Cycle 2 3 2003 258 262
54. B. Yan, M. Zemskova, S. Holder, V. Chin, A. Kraft, and P.J. Koskinen The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death J. Biol. Chem. 278 46 2003 45358 45367
55. M. Zörnig, T. Schmidt, H. Karsunky, A. Grzeschiczek, and T. Möröy Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2 Oncogene 12 1996 1789 1801